The results of the Diabetes Control and Complications Trial (DCCT) showed an outstanding benefit of almost 70 percent reduction in microvascular disease when driving down A1C to 7, but also showed a higher frequency of hypoglycemia -- events that patients don’t forget. "It was clear intensive therapy back then came with a significant price."
- Posted June 18, 2014 by John L. Leahy, MD
- Posted November 19, 2013 by Doron Schneider, MD, FACP
Obstructive sleep apnea is a common and underdiagnosed condition in patients with type 2 diabetes. This blog post explores what is known about the underlying mechanism that may relate sleep apnea to diabetes.